Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
Background Early recurrence of hepatocellular carcinoma (HCC) is a major obstacle to improving the prognosis, and no widely accepted adjuvant therapy guideline for patients post-liver resection is available. Currently, all available methods and biomarkers are insufficient to accurately predict post-...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
PeerJ Inc.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3e08f6c374c74528b081541cbed5fc68 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|